Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation

BACKGROUND: The clinical use of chromatin-modulating drugs, such as histone deacetylase inhibitors, for the treatment of bone marrow failure and hematopoietic malignancies has increased dramatically over the last few years. Nonetheless, little is currently known concerning their effects on myelopoie...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bartels, Marije, Geest, Christian R., Bierings, Marc, Buitenhuis, Miranda, Coffer, Paul J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Ferrata Storti Foundation 2010
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2895027/
https://ncbi.nlm.nih.gov/pubmed/20107159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.008870
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi